Back to Search
Start Over
Measuring Clinical Treatment Response in Myasthenia Gravis
- Source :
- Neurologic Clinics. 36:339-353
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
-
Abstract
- In this article we provide an overview of health-related outcome measurement-to better understand what different outcomes used in myasthenia actually measure-and to provide some guidance when choosing measures based on the clinical context and question. In myasthenia, the most commonly used outcome measures are aimed at assessing the signs and symptoms. In this review, we provide a summary of the most commonly used outcome measures. We discuss instruments that gauge disease overall health impact, such as on disability and quality of life. Finally, we discuss other relevant outcomes such as steroid-sparing effects and the role of surrogate markers.
- Subjects :
- medicine.medical_specialty
business.industry
Minimal Clinically Important Difference
Outcome measures
Signs and symptoms
Context (language use)
Disease
medicine.disease
Outcome (game theory)
Article
Myasthenia gravis
Disability Evaluation
03 medical and health sciences
0302 clinical medicine
Quality of life (healthcare)
Myasthenia Gravis
medicine
Humans
030212 general & internal medicine
Neurology (clinical)
Intensive care medicine
business
Clinical treatment
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 07338619
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Neurologic Clinics
- Accession number :
- edsair.doi.dedup.....d2ac47552dbd30bb602a10a02cf00862